International chemical group Solvay posted a 2% increase in net income for Q2 2012, with net sales at 3,331m ($4,088m), although volumes were 6% down compared with last years results.
Improvements were seen in the special chemicals division, which encompasses the companys fluorchemicals business, with REBITA* reported at 20m ($24.5m), compared to 12m in Q1 2012 and 26m in Q2 2011. ...